Atlas Trials

Rakuten Medical, Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Rakuten Medical, Inc.

RecordFirmDate
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases (NCT06699212)Rakuten Medical, Inc.2024-12-24
ASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Recurrent Head and Neck Cancer, With or Without Metastases (NCT05265013)Rakuten Medical, Inc.2022-04-19
RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and HNSCC (NCT05220748)Rakuten Medical, Inc.2022-03-24
ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer (NCT05182866)Rakuten Medical, Inc.2022-01-21
An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors (NCT04305795)Rakuten Medical, Inc.2020-12-21

Track Rakuten Medical, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.